Estimates of islet area and numbers and endocrine cell composition in the adult human pancreas vary from several hundred thousand to several million and beta mass ranges from 500 to 1500 mg [1] [2] [3] . With this known heterogeneity, a standard processing and staining procedure was developed so that pancreatic regions were clearly defined and islets characterized using rigorous histopathology and immunolocalization examinations.
1. Select the Dako program for double stains and input numbers of slides. Prepare TBST and citrate buffers, antibodies, and other reagents according to specified volumes ( Table 1) . Load the reagent tray and slides. Rotation of clean and waste lines are programmed according to manufacturer's recommendations. 2. If performing these assays manually, prepare estimated volumes. Incubate slides in a humidified chamber to avoid slides drying out at any step. Follow the same procedure for each reagents as when used for the autostainer.
1. Put slides in xylene for 5 minutes. Repeat once. Do not allow the slides to dry out at any subsequent point until indicated as this will result in excessive background and poor staining. 2. Transfer slides to 100% ethanol for 2 minutes. Repeat once.
3. Put slides in freshly prepared 3% H2O2 in methanol for 10 minutes.
4. Dip slides in 90% Ethanol and then place in 90% Ethanol for 3 minutes.
5. Transfer slides to 70% Ethanol for 1 minute.
6. Rinse slides in de-ionized water.
7. Preheat steamer and citrate buffer in steamer for 5 minutes.
8. Add slides to citrate buffer in the steamer and steam for 30 minutes.
9. Immediately transfer slides to water and hold until slides cool to room temperature (~20 minutes). 10. Transfer slides to the Dako autostainer racks according to stain sequence (Figure 1 ) and run the double staining program. The major steps of the autostainer program are listed so that manual runs can duplicate. 8. Incubate slides in TBS pH 7.6 for 1 minute. Rinse twice with water.
9. Unload slides from DAKO Autostainer.
10. Immediately dehydrate slides stained for pancreatic polypeptide. For all double stained slides, dry for at least 1 hour then dehydrate.
1. Place slides in 80% ethanol for 1 minute.
2. Dip slides in 95% ethanol.
3. Hold slides in 95% ethanol for 30 seconds.
4. Transfer slides to 100% ethanol and hold 1 minute. Repeat.
Dip slides in xylene.
6. Hold slides in xylene for 1 minute. Repeat.
7. Immediately mount coverslips on slides using cytoseal.
Representative Results
These staining procedures were developed for the JDRF Network for Pancreatic Organ donors with Diabetes (nPOD) to provide baseline characterization of paraffin and fresh frozen blocks. Each donor has a baseline characterization performed comprised of staining 2 blocks from each pancreas region (head, body, and tail) and the spleen (Figure 1 , see also case submission form, Appendix 1). The H&E staining is conducted using an autostainer programmed as for a clinical facility with clinical-grade solutions used throughout. As additional donor blocks are sectioned, each has a slide taken for H&E to show tissue morphology. When blocks are sectioned again, as for distribution to investigators, deeper levels will also have slides taken for representative H&E slides to document the entire block's tissue morphology as well as numbering serial sections at each level. Stained slides are labeled with case identification, pancreas region, block number, stain and date (Figure 2) and scanned into the online pathology information management system. Representative images from a control donor are shown in Figure 3 at both low and high magnifications to show expected results following this procedure. The slide stained with pancreatic polypeptide (D,H) was assayed on a different day with the assay performed manually and shows reduced staining intensity of the hematoxylin counterstain. Differences in staining intensity of primary antibodies or counterstain between assays is to be avoided particularly if using image analysis otherwise slides with require individual color correction to achieve the same cell areas or counts.
Each laboratory should expect to optimize antibody concentrations as lot-to-lot variation and other reagents and conditions can impact staining intensity and specificity. With acquisition of new reagents, staining procedures are validated with known positive and negative control samples to achieve the same degree of stain intensity as with former reagents. Additional antibodies optimized in the nPOD pathology core are provided in Table 2 as a reference source and have been used for multilabeling immunofluorescence assays for confocal microscopy. 
Discussion
Standardization of IHC procedures is critical for image analysis, particularly when using computer-based algorithms across large numbers of slides over time. The IHC staining procedure described in this report will allow batch analysis of a given donor's samples using an autostainer within an 8-hour work day and are modified from a previous report 5 . Digitized whole slide images of each stained slide made available to nPOD-affiliated investigators through the web-based online pathology system. Investigators can review donor demographics, laboratory data, and other pertinent clinical history along with the slides and are able to choose blocks most suitable for their studies (see http://www.jdrfnpod.org/online-pathology.php for more information). Such an online pathology system serves as a "virtual biobank". A further improvement to this system will be implemented whereby slide labels incorporate a bar code to track serial sections and levels for each block with an eventual goal of 3-D reconstruction of the pancreas.
The two double staining procedures were primarily chosen to determine islet β-cell composition (insulin) in concert with cellular replication (Ki-67) given the importance of understanding mechanisms for adult β-cell regeneration in type 1 diabetes 5, 6 . As the second double IHC assay is performed on serial sections to the first, each islet is characterized for both β-cell (insulin) and α-cell composition (glucagon). In addition, the presence of T-lymphocytes (CD3) is determined in conjunction with α-cell staining for two main reasons. The basis of T-cell mediated autoimmunity in progression of type 1 diabetes has been clearly appreciated yet the nature of the initiating agents (viral, bacterial, inflammatory cells) or the composition of the chronic infiltrate with resultant β-cell dysfunction and demise are yet to be defined (reviewed in 7, 8 ). Second, donors with type 1 diabetes have a well characterized deficiency of β-cells so that combination of the CD3 and glucagon stains ensures identification of islets even when β-cell loss is severe 9 .
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